Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sulzer Inter-Op Hip Shell Loosening Detected In 129 Patients Following Recall

This article was originally published in The Gray Sheet

Executive Summary

The financial impact of Sulzer Orthopedics' Inter-Op acetabular shell hip implant recall Dec. 5 "will be more than offset" by a $32 mil. one-time payment from a separate litigation settlement to its Sulzer Spine-Tech subsidiary, the firm predicts.

You may also be interested in...



Centerpulse/Sulzer Cuts Settlement Opt-Outs To 87, Sidesteps Bankruptcy

Centerpulse plans to "aggressively defend" in court any outstanding claims related to its Inter-Op hip implant and Natural Knee II recalls that were not part of a class settlement, but the firm has not ruled out the possibility of settling those claims out of court

Sulzer Changes Name To Centerpulse, Will Approve Class Settlement May 22

Sulzer Medica will attempt to reduce the financial impact of 132 opt-out cases from its class action settlement, reiterating that the firm may file for Chapter 11 bankruptcy to avoid settling those claims

Sulzer Changes Name To Centerpulse, Will Approve Class Settlement May 22

Sulzer Medica will attempt to reduce the financial impact of 132 opt-out cases from its class action settlement, reiterating that the firm may file for Chapter 11 bankruptcy to avoid settling those claims

Related Content

UsernamePublicRestriction

Register

OM016193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel